NOTIFICATION OF TRANSACTIONS OF DIRECTORS' DEALINGS
Oxford Instruments plc (the "Company") announces that the following director's
dealing took place:
On 11 December 2013, Kevin Boyd acquired ordinary shares of 5p each in the
Company upon the exercise of approved options granted under the Oxford
Instruments 2001 Executive Share Option Scheme "ESOS". All shares acquired in
this way were retained by the director.
ESOS Options exercised and shares sold
No. of Base option No. of Shares Shares
options price shares sold retained
exercised acquired
Kevin Boyd 7,371 203.5p 7,371 nil 7,371
Finance Director
Following this transaction, Kevin Boyd now holds the following number of
ordinary shares of 5p in the Company:-
Kevin Boyd
Finance Director
Interest in shares before 78,914
notification
Total interest in shares 86,285
following this notification
% of issued share capital 0.15%
This notice is given in fulfilment of the obligations under DTR 3.1.4R(1)
11 December 2013
Susan Johnson-Brett
Company Secretary
Oxford Instruments plc
Tel: 01865 393324
Email: susan.johnson-brett@oxinst.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.